TABLE 2.
Formation of heterologous RV VLS
Co-expressiona | VLS formationc | Co-expressionb | VLS formation | ||
---|---|---|---|---|---|
NSP5 species |
NSP2-HA species | NSP5-BAP species | NSP2-HA species | ||
RVA | RVA | + | RVA | RVA | + |
RVA | RVB | − | RVB | RVA | − |
RVA | RVC | +, filamentous/globular | RVC | RVA | − |
RVA | RVD | _ | RVD | RVA | −, nuclear aggregates |
RVA | RVF | − | RVF | RVA | −, nuclear inclusions |
RVA | RVG | − | RVG | RVA | −, aggregates |
RVA | RVH | − | RVH | RVA | − |
RVA | RVI | + | RVI | RVA | − |
RVA | RVJ | − | RVJ | RVA | − |
Confirmed by co-immunostaining of NSP5 of RVA and NSP2 HA of species A–J using specific guinea pig pAb anti-NSP5 and mAb anti-HA, respectively.
Confirmed by co-immunostaining of NSP5-BAP of species A to J and NSP2-HA of RV species A using StAv and mAb anti-HA, respectively.
The result corresponds to the observation of three independent experiments.